KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verisign (VRSN) Receivables (2016 - 2026)

Verisign has reported Receivables over the past 18 years, most recently at $11.3 million for Q1 2026.

  • Quarterly Receivables changed N/A to $11.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.3 million through Mar 2026, changed N/A year-over-year, with the annual reading at $7.7 million for FY2025, 37.5% up from the prior year.
  • Receivables was $11.3 million for Q1 2026 at Verisign, up from $7.7 million in the prior quarter.
  • Over five years, Receivables peaked at $11.3 million in Q1 2026 and troughed at $3.3 million in Q3 2025.
  • The 5-year median for Receivables is $5.6 million (2024), against an average of $5.8 million.
  • Peak annual rise in Receivables hit 61.11% in 2025, while the deepest fall reached 45.0% in 2025.
  • Tracing VRSN's Receivables over 5 years: stood at $6.2 million in 2022, then grew by 1.61% to $6.3 million in 2023, then decreased by 11.11% to $5.6 million in 2024, then surged by 37.5% to $7.7 million in 2025, then skyrocketed by 46.75% to $11.3 million in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $11.3 million, $7.7 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.